Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR211: a peripheral CB1 receptor antagonist”（2018/12/17）
Title: NHRI technology, “DBPR211: a peripheral CB1 rece …
產學研發-EN
Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR114: a multi-targeted kinase inhibitor for solid tumors”（2018/12/13）
Title: NHRI technology, “DBPR114: a multi-targeted kina …
